EGFR and lung carcinoma: Therefore, the core compounds identified in this study can be used as potential therapeutic drugs for lung cancer, and their anti-inflammatory activities can provide a pharmacological reference for alleviating the adverse reaction of diarrhea to EGFR-TKI.